Enovis (ENOV) Non-Current Debt (2010 - 2026)
Enovis (ENOV) posted quarterly Non-Current Debt of $1.3 billion for Q2 2026, down 5.6% year-over-year from $1.4 billion in Q2 2025, and up 2.31% quarter-over-quarter from $1.3 billion in Q4 2025.
Enovis (ENOV) Non-Current Debt (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Non-Current Debt for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Debt fell 5.6% year-over-year to $1.3 billion; the TTM figure through Apr 2026 stood at $1.3 billion (down 5.6% YoY), while the FY2025 annual figure was $1.3 billion, down 5.09% from the prior year.
- Non-Current Debt advanced to $1.3 billion in Q2 2026 per ENOV's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $2.1 billion in Q2 2022 and bottomed at $40.0 million in Q4 2022.
- Historically, Non-Current Debt has averaged $973.3 million across 5 years, with a median of $1.3 billion in 2026.
- Annual changes were most pronounced in 2022 — Non-Current Debt tumbled 98.08% — and 2023, when it jumped 1065.41%.
- Enovis' Non-Current Debt stood at $40.0 million in 2022, then surged by 1065.41% to $466.2 million in 2023, then jumped by 185.2% to $1.3 billion in 2024, then decreased by 5.09% to $1.3 billion in 2025, then advanced by 2.31% to $1.3 billion in 2026.
- Business Quant data shows ENOV's Non-Current Debt at $1.3 billion in Q2 2026, $1.3 billion in Q4 2025, and $1.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Enovis | 1.52 Bn | 1.51 Bn | 359.25 Mn | 1.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 1.28 Bn |
| Apr 3, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Oct 3, 2025 | 1.36 Bn |
| Jul 4, 2025 | 1.37 Bn |
| Apr 4, 2025 | 1.37 Bn |
| Dec 31, 2024 | 1.33 Bn |
| Sep 27, 2024 | 1.33 Bn |
| Jun 28, 2024 | 1.34 Bn |
| Mar 29, 2024 | 1.34 Bn |
| Dec 31, 2023 | 466.16 Mn |
| Sep 29, 2023 | 395.00 Mn |
| Jun 30, 2023 | 400.00 Mn |
| Mar 31, 2023 | 285.00 Mn |
| Dec 31, 2022 | 40.00 Mn |
| Sep 30, 2022 | 449.22 Mn |
| Jul 1, 2022 | 449.46 Mn |
| Apr 1, 2022 | 2.07 Bn |
| Dec 31, 2021 | 2.09 Bn |
| Oct 1, 2021 | 1.61 Bn |